Literature DB >> 10215963

Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone.

M G Mazzucconi1, M Peraino, L Bizzoni, S Bernasconi, M Luciani, G D Rossi.   

Abstract

The occurrence of acquired inhibitor against factor IX:C is infrequent in haemophilia B patients and is very rare in previously healthy subjects, in whom it is often related to underlying diseases. We describe the case of a 2-year-old girl, who was referred to our hospital with haematomas, without previous bleeding history. Prolonged APTT, normal PT and a factor IX:C level below 1% were found. An inhibitor against factor IX:C was detected (5.5 U mL(-1)). Her father and mother showed normal factor IX:C levels. Treatment with high-dose immunoglobulin (400 mg kg(-1) day(-1) for 5 consecutive days by intravenous infusion) and dexamethasone (4 mg three times a day by intravenous injection for 4 consecutive days) normalized factor IX:C levels and overcame the inhibitor. In conclusion, high-dose immunoglobulin and high-dose dexamethasone are a successful and safe immunosuppressive approach for recovery from inhibitor occurrence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215963

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

1.  Management of rare acquired bleeding disorders.

Authors:  Marzia Menegatti; Eugenia Biguzzi; Flora Peyvandi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.

Authors:  Saša Anžej Doma; Andreas Hillarp; Tadej Pajič; Dušan Andoljšek; Peter Černelč; Irena Preldžnik Zupan
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.